Also known as Hepatolenticular degeneration, Lenticular degeneration, Cerebral pseudosclerosis Kinnier Wilson disease, Westphal's pseudosclerosis and Westphal-Strumpell syndrome
Wilson's disease is present at birth, but signs and symptoms don't appear until copper builds up in the brain, liver, or other organs. The signs and symptoms depend on the parts of the body affected by the disease. These include:
In Wilson's disease, the majority of patients present with hepatic symptoms at diagnosis, and almost all have signs of liver damage over the course of the disease. In some cases, people develop these symptoms when they have acute liver failure. These symptoms may include:
In some individuals, symptoms of the disease develop in cases of chronic liver disease and complications from cirrhosis. The clinical features of cirrhosis include spider naevi, splenomegaly, portal hypertension, and ascites. It is recommended that all young patients with unexplained chronic liver disease, with or without cirrhosis, should be screened for Wilson’s disease if the following symptoms are present:
Neurological and neuropsychiatric signs are present in 40–50% of patients with Wilson’s disease. Some signs may appear before the characteristic neurological features, including changes in behavior, deterioration of school work, or an inability to carry out activities requiring good hand-eye coordination. Common neurological symptoms may include:
Mood disturbances, along with behavioral changes, may include:
The main ophthalmic findings of Wilson’s disease include:
Other less common symptoms include:
Pathological changes in bone have been recorded to account for osteomalacia, osteoporosis, spontaneous fractures, adult rickets, and osteoarthritis.
Copper accumulation in heart tissues can cause cardiomyopathy and arrhythmias.
Other rare manifestations include hypoparathyroidism, infertility, repeated miscarriages, and kidney abnormalities.
Wilson's disease is caused by changes (mutations) in the ATP7B gene. This gene encodes a protein that plays an important role in the transport of copper from the liver to the rest of the body. Mutations in the ATP7B gene prevent this protein from functioning properly, leading to an accumulation of copper in the body.
The ATP7B mutations that cause Wilson's disease are inherited, meaning they are passed from parent to child. These mutations are autosomal recessive, which means a person must inherit two ATP7B genes with mutations—one from each parent—to develop Wilson's disease. Individuals who possess one ATP7B gene without a mutation and one ATP7B gene with a mutation do not have Wilson's disease; however, they are carriers of the disease.
The risk of Wilson’s disease is genetic; it is inherited, and the risk increases if your parents or siblings have the condition. A genetic test can be performed if a child shows symptoms of Wilson’s and has one or both parents who have the disease.
There is no one test for the diagnosis of Wilson’s disease. The diagnostic challenge is that the symptoms are often nonspecific and the disease affects many different organ systems, resulting in confusion with other disorders. Many symptoms may evolve over time rather than appear all at once. In a few cases, the diagnosis is easy to establish in individuals with neurological symptoms, K-F rings, and a low ceruloplasmin concentration. Doctors diagnose Wilson's disease based on medical and family history, a physical exam, an eye exam, and tests.
A doctor will inquire about the family and personal medical history of Wilson's disease and other conditions that could be causing the symptoms.
During a physical exam, the doctor will look for physical signs related to Wilson’s disease.
Using a microscope with a high-intensity light source (slit lamp), an ophthalmologist checks the eye for Kayser-Fleischer rings, which are caused by excess copper in the eyes. Wilson's disease is also associated with a sunflower cataract, which can be seen during an eye exam.
The doctor may order one or more blood tests, including tests that check amounts of:
A 24-hour urinary copper excretion is increased in Wilson’s disease, reflecting the amount of serum-free copper in circulation. In symptomatic individuals, a urinary copper excretion in a 24-hour period of greater than 1.6 μmol (greater than 100 μg/24 h) is considered diagnostic. The reference limits for normal 24-hour excretion of copper vary between laboratories, with many considering 40 μg per 24 h (0.6 μmol/24 h) as the upper limit of normal.
Liver biopsy is an important tool for evaluating patients with hepatic disease if the results of blood and urine tests do not confirm or rule out a diagnosis of Wilson's disease. During a liver biopsy, the doctor evaluates small pieces of tissue from the liver. A pathologist examines the tissue under a microscope to look for features of specific liver diseases, such as Wilson's disease, and checks for liver damage and cirrhosis.
All first-degree relatives of a patient with newly diagnosed Wilson’s disease must be screened for the disease. Molecular genetic analysis can be useful for families where both mutations have been identified in the index patient, enabling molecular analysis for the same mutation in family members.
Neurologic evaluation and radiologic imaging of the brain should be considered prior to treatment in all patients with neurologic Wilson’s disease and should be part of the evaluation of any patient presenting with neurological symptoms:
Wilson’s disease is a genetic disorder. People with a family history of Wilson’s disease should always seek genetic counseling as part of pregnancy planning.
Genetic counseling provides a means to:
This process enables individuals and families to gain better insight into their future.
Successful treatment of Wilson’s disease depends upon timing more than medication. Treatment often occurs in stages and should last a lifetime. If a person stops taking the required medications, copper can build back up again. Compliance is a challenge for patients because they find it difficult to adhere to life-long treatment when they feel healthy. The various treatment modalities are discussed in detail:
The first treatment is to remove excess copper from the body through chelation. Penicillamine and trientine are chelating agents used to treat Wilson's disease. These medications work by binding excess copper in body tissues and carrying it to the kidneys, where it is ultimately removed via urine.
The second stage involves maintaining normal levels of copper after removal. The doctor may prescribe zinc or ammonium tetrathiomolybdate to prevent the intestines from absorbing copper.
Note: Penicillamine or trientine must not be taken at the same time as zinc because either drug can bind with zinc, forming a compound with no therapeutic effect.
After symptoms improve and copper levels normalize, doctors typically focus on long-term maintenance therapy. This includes continuing zinc or chelating therapy and regularly monitoring copper levels. Patients should also avoid foods high in copper, such as dried fruits, mushrooms, nuts, chocolate, shellfish, and multivitamins.
Toxic concentrations of copper in the liver produce oxidant damage to mitochondria with lipid peroxidation, which can be reduced experimentally by vitamin E administration. Vitamin E concentrations may be low in patients with Wilson’s disease.
Liver transplantation may be lifesaving for patients with severe Wilson’s disease or severe hepatic insufficiency unresponsive to drugs. Liver transplantation is a curative therapy, with neurologic and psychiatric conditions stabilizing or improving, and Kayser-Fleischer rings disappearing over time.
Cirrhosis of the liver
Cirrhosis of the liver is one of the potential complications that may develop from Wilson's disease. As the patient's body attempts to clear the buildup of excess copper from the liver, scar tissue is formed, compromising normal liver function. During the early stages of cirrhosis, patients may be asymptomatic, with symptoms appearing only in the most advanced stages. In the later stages, the symptoms of cirrhosis include:
For patients with Wilson's disease, liver abnormalities can begin as early as six years of age.
Kidney stones
Patients with Wilson's disease have an increased risk of developing kidney stones, which are formed from tiny deposits of salts and minerals that are normally filtered by the kidneys. Due to their increased risk for kidney stones, it is recommended that patients with Wilson's disease have an annual x-ray to check for any stones. If small stones are found, these can often be passed with the help of pain relievers, alpha-blockers, and plenty of fluids. Larger stones may require other surgical interventions.
Hemolysis
Hemolysis is characterized by the abnormal destruction of red blood cells and is a potential complication for patients with Wilson's disease. This condition causes patients to feel fatigued, and they may also have an increased heart rate and an enlarged spleen or liver. Patients may feel weak and could become dizzy or confused.
Neurological issues
Patients with Wilson's disease may experience a variety of neurological issues. These may include:
Some individuals might experience involuntary muscle movements or twitching, and speech difficulties have been observed. For some patients, neurological issues could be accompanied by psychological changes such as:
Bipolar disorder and episodes of psychosis may develop.
All Wilson's disease patients need to take some type of medication therapy to remove excess dietary copper every day, for life. In some cases, Wilson’s disease patients may benefit from additional forms of therapy to help control emotional or physical symptoms or regain lost movement or speech. These other forms of therapy may include:
Physical therapy restores function for individuals who have neuromuscular or skeletal problems like arthritis, osteoporosis, joint and muscle pain, and coordination issues. The physical therapy will include:
Occupational therapy assists individuals with adapting to their social and physical environment. Therapists help improve function through:
People with Wilson’s disease may experience a range of psychological disorders over their lifetimes. Depression is the most common and may occur at a rate more than double that of the general population. The feelings that the person may experience include:
If any of these are suspected, get in touch with your personal physician or mental health professional for an evaluation.
Self-care
Self-care is an integral part of daily life. It means taking responsibility for your health and well-being, with support from those involved in your care. Self-care involves activities to stay fit, maintain good mental and physical health, and effectively manage other minor ailments.
Low copper diet
Foods with a high concentration of copper should generally be avoided, especially in the first year of treatment when excess copper is being cleared from the body. These foods include:
- Liver
- Cashews
- Black-eyed peas
- Vegetable juice
- Shellfish
- Mushrooms
- Chocolate
- Cocoa
Regular follow-ups with doctors
Poor long-term adherence to drug therapy for Wilson’s disease is common. However, continual, lifelong treatment of Wilson’s disease is essential, regardless of whether symptoms are present. Regular follow-up care with an expert in liver disease is highly recommended.
References